Alani Selvey

Alani Selvey has a diverse work experience in the pharmaceutical industry. In 2007, Selvey joined Arena Pharmaceuticals as a Senior Fellow, where they worked until 2015. Following that, they joined Ophthotech in 2016 as the Director of New Product Development, staying until 2017. In 2017, Selvey established their own company called Silvey & Selvey Enterprises, LLC, where they served as the President and CMC Drug Development Consultant. Selvey's most recent position is as the Senior Vice President of CMC at Anavex Life Sciences, which they began in 2018 and continues to hold.

Alani Selvey pursued a Ph.D. in Physical Chemistry at Duke University, although the exact start and end years of their education are unknown.